Foehr Matthew W's Form 4 filing
Ligand Pharmaceuticals Inc (LGND) · filed Aug 5, 2021
- Accession no.
- 0000886163-21-000121
- Filed
- Aug 5, 2021
- Trade date
- Aug 4, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $969.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Foehr Matthew WCIK 0001237556 | Officer (President and COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2021 | Common Stock | MOption exerciseAcquired | +8,840 | $21.92 | +$193,772.8 | 173,195 | Direct | |
| Aug 4, 2021 | Common Stock | SSaleDisposed | −8,840 | $109.67F1 | −$969,482.8 | 164,355 | Direct | |
| Aug 4, 2021 | Common Stock | MOption exerciseAcquired | +1,142 | $85.79 | +$97,972.18 | 165,497 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2021 | Common Stock | MOption exerciseDisposed | −8,840 | $0.00 | $0 | 11,160 | Direct | |
| Aug 4, 2021 | Common Stock | MOption exerciseDisposed | −1,142 | $0.00 | $0 | 25,938 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.06 to $111.00, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.